EP2604110A3
Animal models and therapeutic molecules
Abstract
The invention discloses methods for the generation of chimaeric human - non human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods.
Term
Projected expiry 7 July 2030.
- Priority and filed
- Published
- Today
- Projected expiry
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO02066630A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| US2006015957A1 | Cites | United States of America | Search report |
| WO2007117410A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO2008094178A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO2009080254A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| SHULTZ L D ET AL: "Humanized mice in translational biomedical research", THE JOURNAL OF IMMUNOLOGY, NATURE PUB. GROUP, vol. 7, no. 2, February 2007 (2007-02-01), pages 118 - 130, XP002493022, ISSN: 1474-1733, DOI: 10.1038/NRI2017 | Non-patent | – | Search report |
| LONBERG NILS: "Human antibodies from transgenic animals", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 23, no. 9, September 2005 (2005-09-01), pages 1117 - 1125, XP002442149, ISSN: 1087-0156, DOI: 10.1038/NBT1135 | Non-patent | – | Search report |
432 members in 26 offices
Members432
| Document | Office | Kind | |
|---|---|---|---|
| GB609904A | United Kingdom | A | |
| GB0911846D0 | United Kingdom | D0 | |
| GB0913102D0 | United Kingdom | D0 | |
| CA2767436A1 | Canada | A1 | |
| WO2011004192A1 | World Intellectual Property Organization (WIPO) | A1 | |
| GB201116120D0 | United Kingdom | D0 | |
| GB201116122D0 | United Kingdom | D0 | |
| CA2802591A1 | Canada | A1 | |
| WO2011158009A1 | World Intellectual Property Organization (WIPO) | A1 | |
| GB201122047D0 | United Kingdom | D0 | |
| AU2010269978A1 | Australia | A1 | |
| SG177380A1 | Singapore | A1 | |
| EP2421357A1 | European Patent Office (EPO) | A1 | |
| GB201203257D0 | United Kingdom | D0 | |
| GB201204592D0 | United Kingdom | D0 | |
| GB201205702D0 | United Kingdom | D0 | |
| GB201207814D0 | United Kingdom | D0 | |
| US2012167237A1 | United States of America | A1 | |
| US2012167237A1 | United States of America | A1 | |
| GB201208708D0 | United Kingdom | D0 | |
| GB201208749D0 | United Kingdom | D0 | |
| US2012204278A1 | United States of America | A1 | |
| US2012204278A1 | United States of America | A1 | |
| CN102638971A | China | A | |
| GB201211692D0 | United Kingdom | D0 | |
| HK1162119A | Hong Kong, China | A | |
| HK1162119A1 | Hong Kong, China | A1 | |
| HK1162119A1 | Hong Kong, China | A1 | |
| EP2517556A2 | European Patent Office (EPO) | A2 | |
| EP2517557A2 | European Patent Office (EPO) | A2 | |
| GB201216795D0 | United Kingdom | D0 | |
| JP2012532598A | Japan | A | |
| EP2421357B1 | European Patent Office (EPO) | B1 | |
| SG186238A1 | Singapore | A1 | |
| AU2011266843A1 | Australia | A1 | |
| US2013042331A2 | United States of America | A2 | |
| US2013042331A2 | United States of America | A2 | |
| EP2564695A1 | European Patent Office (EPO) | A1 | |
| CA2846319A1 | Canada | A1 | |
| CA2846322A1 | Canada | A1 | |
| WO2013041844A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2013041845A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2013041846A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2011266843A2 | Australia | A2 | |
| DK2421357T3 | Denmark | T3 | |
| PT2421357E | Portugal | E | |
| HK1172207A | Hong Kong, China | A | |
| HK1172207A1 | Hong Kong, China | A1 | |
| HK1172207A1 | Hong Kong, China | A1 | |
| EP2582230A1 | European Patent Office (EPO) | A1 | |
| KR20130042461A | Republic of Korea | A | |
| WO2013061098A2 | World Intellectual Property Organization (WIPO) | A2 | |
| ES2403087T3 | Spain | T3 | |
| HRP20130253T1 | Croatia | T1 | |
| HRP20130253T1 | Croatia | T1 | |
| CA2857569A1 | Canada | A1 | |
| WO2013079953A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP2604110A2 | European Patent Office (EPO) | A2 | |
| EP2604111A2 | European Patent Office (EPO) | A2 | |
| WO2013061098A3 | World Intellectual Property Organization (WIPO) | A3 | |
| SI2421357T1 | Slovenia | T1 | |
| SMT201300046B | San Marino | B | |
| SMT201300046B | San Marino | B | |
| WO2013041844A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2517556A3 | European Patent Office (EPO) | A3 | |
| EP2517557A3 | European Patent Office (EPO) | A3 | |
| CN103228130A | China | A | |
| PL2421357T3 | Poland | T3 | |
| WO2013041846A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2013041845A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2604110A3This record | European Patent Office (EPO) | A3 | |
| US2013243759A1 | United States of America | A1 | |
| CA2867530A1 | Canada | A1 | |
| US2013263292A1 | United States of America | A1 | |
| US2013263293A1 | United States of America | A1 | |
| WO2013144566A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2013144567A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP2649184A1 | European Patent Office (EPO) | A1 | |
| HK1180535A | Hong Kong, China | A | |
| HK1180535A1 | Hong Kong, China | A1 | |
| HK1180535A1 | Hong Kong, China | A1 | |
| NZ597481A | New Zealand | A | |
| GB2501753A | United Kingdom | A | |
| GB2502127A | United Kingdom | A | |
| WO2013144566A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2013171505A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2013318643A1 | United States of America | A1 | |
| US2013318643A1 | United States of America | A1 | |
| EP2604111A3 | European Patent Office (EPO) | A3 | |
| WO2013171505A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2014041067A1 | United States of America | A1 | |
| HK1185100A | Hong Kong, China | A | |
| HK1185100A1 | Hong Kong, China | A1 | |
| AU2012311286A1 | Australia | A1 | |
| AU2012311288A1 | Australia | A1 | |
| US2014120582A1 | United States of America | A1 | |
| US2014120582A1 | United States of America | A1 | |
| AU2012343587A1 | Australia | A1 | |
| US2014134156A1 | United States of America | A1 | |
| US2014134156A1 | United States of America | A1 |
Showing 100 of 432
97 legal events, as 12 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Translation for ep filed (entry of ep into country)FP | FP | BE | |
| Patent revokedRevoked27W | 27W | EP | |
| Gb: patent revoked under art. 102 of the ep convention designating the uk as contracting stateRevokedGBPR | GBPR | EP | |
| Patent revokedRevokedORIGINAL CODE: 0009271RDAG | RDAG | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT REVOKEDSTAA | STAA | EP | |
| Communication despatched that patent is revokedRevokedORIGINAL CODE: EPIDOSNREV1RDAF | RDAF | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Epo's revocation decision now finalR064 | R064 | DE | |
| Patent revoked by epoRevokedR103 | R103 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Reply of patent proprietor to notice(s) of opposition receivedOppositionORIGINAL CODE: EPIDOSNOBS3PLBB | PLBB | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Standard patents granted in hong kongGrantedGR | GR | HK | |
| Opposition filedOpposition26 | 26 | EP | |
| Notice of opposition and request to file observation + time limit sentOppositionORIGINAL CODE: EPIDOSNOBS2PLAX | PLAX | EP | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Opposition filed against patentOppositionR026 | R026 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Invalidated european patentMG4D | MG4D | LT | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Translation for ep filed (entry of ep into country)FP | FP | NL | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Amendment of ipc main classPREVIOUS MAIN CLASS: A01K0067027000R079 | R079 | DE | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Observations filed by third partiesORIGINAL CODE: EPIDOSNTIPATPAC | TPAC | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Observations filed by third partiesORIGINAL CODE: EPIDOSNTIPATPAC | TPAC | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting states (corrected)RBV | RBV | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Designated contracting statesAK | AK | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2604110
- Application
- 121949770
Titles3
- German
- Tiermodelle und therapeutische Moleküle
- English
- Animal models and therapeutic molecules
- French
- Modèles animaux et molécules thérapeutiques
Classification
- CPC, 38
- A01K67/0278
- A01K67/027
- A01K2207/15
- A01K2217/052
- A01K2227/105
- A01K2267/01
- C07K16/00
- C07K16/462
- C07K2317/24
- C12N15/8509
- A61P37/02
- A01K67/0275
- C07K16/1239
- C07K16/18
- A01K2217/05
- C07K2317/56
- A01K67/0271
- A01K67/0276
- A01K2217/075
- A01K2217/15
- A61K39/107
- A61K39/35
- A61K2039/505
- C07K16/1203
- C07K2317/515
- C07K2317/52
- C07K2317/567
- C07K2317/76
- C12N2015/8518
- C12N15/85
- C12N5/0606
- C07K16/461
- A01K2217/072
- C07K2317/14
- C07K2317/21
- C07K2317/51
- C07K2317/565
- C07K2317/92
- IPC, 5
- A01K67 027
- C07K16 00
- C07K16 46
- C12N15 85
- C12N15 90
Designated states37
- Contracting states, 37
- Albania
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
and 13 moreShow fewer
- Monaco
- North Macedonia
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- San Marino
- Türkiye